Kineta

graphic image of different colored hands shaking
Biotech

Kineta sells Genentech, Merck deals to investor ahead of merger

Tidying up the portfolio ahead of its merger with TuHURA, Kineta is selling the deals to an investment firm and offloading a pain prospect to Pacira.
Nick Paul Taylor Feb 10, 2025 7:45am
helicopter rescue mission save aircraft

Kineta faces shutdown as private placement fails to show up

Feb 29, 2024 9:32am
handshake

Yumanity's end: J&J pays $26M for neuroscience assets

Jun 6, 2022 9:10am